Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany

Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany

Bibliographic Details
Main Authors:	G. Geiges, C. Winter, K. Katzenberger, M. Kübrich
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320362017

Similar Items

HORMONAL THERAPY WITH LEUPRORELIN (LUCRIN-DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: I. G. Rusakov, et al.
Published: (2014-08-01)

HORMONAL THERAPY WITH LEUPRORELIN (LUCRIN-DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: I. G. Rusakov, et al.
Published: (2014-08-01)

ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01)

ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01)

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009-06-01)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
by: Tunn UW, et al.
Published: (2013-04-01)

LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?
by: V. B. Matveev, et al.
Published: (2014-08-01)

LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?
by: V. B. Matveev, et al.
Published: (2014-08-01)

A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin
by: Dohee Kim, et al.
Published: (2019-10-01)

Clinical development of two innovative pharmaceutical forms of leuprorelin acetate
by: Goetz Geiges, et al.
Published: (2013-02-01)

Clinical studies investigating the use of leuprorelin for prostate cancer in Asia
by: Byung Ha Chung, et al.
Published: (2020-03-01)

Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature
by: Imane Benabbad, et al.
Published: (2018-05-01)

Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls
by: Yang K, et al.
Published: (2021-04-01)

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma
by: Khin Thway, et al.
Published: (2015-01-01)

Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation
by: Mladen Solarić, et al.
Published: (2017-06-01)

Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer.
by: Yixuan Zou, et al.
Published: (2020-01-01)

The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot
by: Ioannis M. Matalliotakis, et al.
Published: (2001-01-01)

Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
by: Seiichi Saito
Published: (2020-03-01)

EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

Update in palliative management of hormone refractory cancer of prostate
by: Pratipal Singh, et al.
Published: (2007-01-01)

Voluntary Interim Auditor Reviews and the Enforcement System in Germany
by: Höhn, Balthasar
Published: (2014)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Analysis Risk Factors of Relapse in The Patients with Prostate Cancer Receiving Radical Prostatectomy and Prostate with Advanced Prostate Cancer Receiving Hormone Therapy
by: Yueh-Ping Chiang, et al.
Published: (2010)

Diffuse Leukoplakia of the Bladder Ostium-Sparing in Patient Treated with Leuprorelin for Breast Cancer
by: Antonio Nacchia, et al.
Published: (2021-01-01)

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment
by: L. Muratori, et al.
Published: (2019-05-01)

Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving Leuplin depot as androgen deprivation therapy.
by: Chien-Hua Chen, et al.
Published: (2014-01-01)

Balloon pulmonary valvotomy as interim palliation for symptomatic young infants with tetralogy of Fallot
by: Remadevi K, et al.
Published: (2008-01-01)

Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.
by: Gina Lama, et al.
Published: (2013-01-01)

Buserelin-depot in the treatment of prostate cancer
by: G. P. Kolesnikov
Published: (2015-09-01)

Effects of a Low-dose Leuprorelin Long Protocol on the Ovarian Response and Cycle Outcome in IVF
by: Yu-Chiao Yi, et al.
Published: (2004-06-01)

Effects of Leuprorelin Acetate, a GnRH Agonist, on the Growth of Uterine Luminal Epithelium in Rats
by: 蕭如玲
Published: (1995)

Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO)
by: Jesper Carl, et al.
Published: (2019-01-01)

Emergency balloon dilation or stenting of critical coarctation of aorta in newborns and infants: An effective interim palliation
by: Francis Edwin, et al.
Published: (2009-01-01)

EMERGENCY BALLOON DILATATION OR STENTING OF CRITICAL COARCTATION OF AORTA IN NEWBORNS AND INFANTS: AN EFFECTIVE INTERIM PALLIATION
by: Edwin Francis, et al.
Published: (2010-09-01)

Wind and wave energy resource of Germany reported by ERA-Interim reanalysis data
by: Rusu Eugen, et al.
Published: (2019-01-01)

Prostate Specific Antigen as a Prognostic Factor for Biochemical Progression of Advanced Prostate Cancer Patients Receiving Hormone Treatment
by: Chien-Hua Chen, et al.
Published: (2009)

“An odyssey without receiving proper care” – experts’ views on palliative care provision for patients with migration background in Germany
by: Maximiliane Jansky, et al.
Published: (2019-01-01)

Postinjection delirium/sedation syndrome with olanzapine depot injection
by: Sadhvi Mythili Sarangula, et al.
Published: (2016-01-01)